MedPath

Mexiletine Hydrochloride

MEXILETINE HYDROCHLORIDE CAPSULES USP

Approved
Approval ID

b1cb1e35-9586-41c4-b43f-c517f2d42f31

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2024

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mexiletine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-1963
Application NumberANDA074450
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mexiletine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJune 22, 2020
FDA Product Classification

INGREDIENTS (11)

MEXILETINE HYDROCHLORIDEActive
Quantity: 200 mg in 1 1
Code: 606D60IS38
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MICROCRYSTALLINE CELLULOSE 101Inactive
Code: 7T9FYH5QMK
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
AMMONIAInactive
Code: 5138Q19F1X
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mexiletine Hydrochloride - FDA Drug Approval Details